NCT01464801View on ClinicalTrials.gov

Resveratrol in Patients With Non-alcoholic Fatty Liver Disease

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

February 28, 2015

Study Completion Date

June 30, 2015

Conditions
Fatty Liver
Interventions
DIETARY_SUPPLEMENT

Resveratrol

Tablet Resveratrol 500 mg 3 times daily for 6 months

DIETARY_SUPPLEMENT

Placebo

Tablet Placebo 3 times daily for 6 months

Trial Locations (1)

8000

Aarhus University Hospital, Dept. of Hepatology and Gastroentology, Aarhus

All Listed Sponsors
collaborator

The Ministry of Science, Technology and Innovation, Denmark

OTHER_GOV

collaborator

Aarhus University Hospital

OTHER

lead

University of Aarhus

OTHER

NCT01464801 - Resveratrol in Patients With Non-alcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter